Correlation Between Vanda Pharmaceuticals and Tango Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Tango Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Tango Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Tango Therapeutics, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Tango Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Tango Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Tango Therapeutics.

Diversification Opportunities for Vanda Pharmaceuticals and Tango Therapeutics

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vanda and Tango is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Tango Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tango Therapeutics and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Tango Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tango Therapeutics has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Tango Therapeutics go up and down completely randomly.

Pair Corralation between Vanda Pharmaceuticals and Tango Therapeutics

Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 0.37 times more return on investment than Tango Therapeutics. However, Vanda Pharmaceuticals is 2.69 times less risky than Tango Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Tango Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  459.00  in Vanda Pharmaceuticals on October 2, 2024 and sell it today you would earn a total of  19.00  from holding Vanda Pharmaceuticals or generate 4.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vanda Pharmaceuticals  vs.  Tango Therapeutics

 Performance 
       Timeline  
Vanda Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vanda Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental indicators, Vanda Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Tango Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tango Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vanda Pharmaceuticals and Tango Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vanda Pharmaceuticals and Tango Therapeutics

The main advantage of trading using opposite Vanda Pharmaceuticals and Tango Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Tango Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tango Therapeutics will offset losses from the drop in Tango Therapeutics' long position.
The idea behind Vanda Pharmaceuticals and Tango Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.